Presentation is loading. Please wait.

Presentation is loading. Please wait.

Fig. 4 The blood path conversion to VAD by relocating the tubing clamps. Stasis in the oxygenator is avoided by recirculating its volume, thus allowing.

Published byMaximilian Arnold Modified over 6 years ago

Similar presentations

Presentation on theme: "Fig. 4 The blood path conversion to VAD by relocating the tubing clamps. Stasis in the oxygenator is avoided by recirculating its volume, thus allowing."— Presentation transcript:

1 Fig. 4 The blood path conversion to VAD by relocating the tubing clamps. Stasis in the oxygenator is avoided by recirculating its volume, thus allowing conversion from ventricular assist back to ECMO if needed. From: Is there a role for extracorporeal life support after stage I Norwood? Eur J Cardiothorac Surg. 2001;19(3): doi: /S (01) Eur J Cardiothorac Surg | © 2001 Elsevier Science B.V. All rights reserved.Elsevier Science B.V.

2 Fig. 3 The blood path during ECMO support.
From: Is there a role for extracorporeal life support after stage I Norwood? Eur J Cardiothorac Surg. 2001;19(3): doi: /S (01) Eur J Cardiothorac Surg | © 2001 Elsevier Science B.V. All rights reserved.Elsevier Science B.V.

3 Table 1 Patient data<sup>a</sup>
From: Is there a role for extracorporeal life support after stage I Norwood? Eur J Cardiothorac Surg. 2001;19(3): doi: /S (01) Eur J Cardiothorac Surg | © 2001 Elsevier Science B.V. All rights reserved.Elsevier Science B.V.

4 Fig. 2 The steps needed to remove the venous cardiotomy reservoir without interrupting support while converting to ECMO support. A 0.25-inch straight connector is positioned in the venous reservoir loop in place of the venous reservoir. From: Is there a role for extracorporeal life support after stage I Norwood? Eur J Cardiothorac Surg. 2001;19(3): doi: /S (01) Eur J Cardiothorac Surg | © 2001 Elsevier Science B.V. All rights reserved.Elsevier Science B.V.

5 Fig. 1 The complete CPB circuit as it is set up in the operating room
Fig. 1 The complete CPB circuit as it is set up in the operating room. Dashed lines represent crystalloid primed components. From: Is there a role for extracorporeal life support after stage I Norwood? Eur J Cardiothorac Surg. 2001;19(3): doi: /S (01) Eur J Cardiothorac Surg | © 2001 Elsevier Science B.V. All rights reserved.Elsevier Science B.V.

6 Table 3 Initiation of support variables
From: Is there a role for extracorporeal life support after stage I Norwood? Eur J Cardiothorac Surg. 2001;19(3): doi: /S (01) Eur J Cardiothorac Surg | © 2001 Elsevier Science B.V. All rights reserved.Elsevier Science B.V.

7 Table 2 Pre-support variables
From: Is there a role for extracorporeal life support after stage I Norwood? Eur J Cardiothorac Surg. 2001;19(3): doi: /S (01) Eur J Cardiothorac Surg | © 2001 Elsevier Science B.V. All rights reserved.Elsevier Science B.V.

8 Table 4 Intra- and post-support variables
From: Is there a role for extracorporeal life support after stage I Norwood? Eur J Cardiothorac Surg. 2001;19(3): doi: /S (01) Eur J Cardiothorac Surg | © 2001 Elsevier Science B.V. All rights reserved.Elsevier Science B.V.

Download ppt "Fig. 4 The blood path conversion to VAD by relocating the tubing clamps. Stasis in the oxygenator is avoided by recirculating its volume, thus allowing."

Similar presentations

Fig. 4-1, p. 107. Fig. 4-2, p. 109 Fig. 4-3, p. 110.

Fig. 4-1, p Fig. 4-2, p. 109 Fig. 4-3, p. 110.
P.464. Table 13-1, p.465 Fig. 13-1, p.466 Fig. 13-2, p.467.

P.464. Table 13-1, p.465 Fig. 13-1, p.466 Fig. 13-2, p.467.
Fig. 11-1, p. 359. p. 360 Fig. 11-2, p. 361 Fig. 11-3, p. 361.

Fig. 11-1, p p. 360 Fig. 11-2, p. 361 Fig. 11-3, p. 361.
Table 6-1, p. 161. Fig. 6-1, p. 162 p. 163 Fig. 6-2, p. 164.

Table 6-1, p Fig. 6-1, p. 162 p. 163 Fig. 6-2, p. 164.
Preoperative Evaluations: The Very Last Chance To Identify a Problem With a Pacemaker or Implanted Cardioverter-Defibrillator Marc A. Rozner, PhD, MD Journal.

Preoperative Evaluations: The Very Last Chance To Identify a Problem With a Pacemaker or Implanted Cardioverter-Defibrillator Marc A. Rozner, PhD, MD Journal.
Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV Erik De Clercq International Journal of Antimicrobial Agents Volume 33,

Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV Erik De Clercq International Journal of Antimicrobial Agents Volume 33,
Immunopathological characterization of selected mouse models of inflammatory bowel disease: Comparison to human disease Yava L. Jones-Hall, Matthew B.

Immunopathological characterization of selected mouse models of inflammatory bowel disease: Comparison to human disease Yava L. Jones-Hall, Matthew B.
Table 1 Cause of death for arrested organ donors

Table 1 Cause of death for arrested organ donors
Fig. 3 Overall and disease-free survival of single-zone metastasis group according to the number of stations involved. No significant differences were.

Fig. 3 Overall and disease-free survival of single-zone metastasis group according to the number of stations involved. No significant differences were.
Table 1 Patient characteristics

Table 1 Patient characteristics
Fig. 1 Diagram of method C for bronchial closure

Fig. 1 Diagram of method C for bronchial closure
Suspected clozapine poisoning in the UK/Eire, 1992–2003

Suspected clozapine poisoning in the UK/Eire, 1992–2003
Suspected clozapine poisoning in the UK/Eire, 1992–2003

Suspected clozapine poisoning in the UK/Eire, 1992–2003
Table 1 Staging of resected tumours of the oesophagus

Table 1 Staging of resected tumours of the oesophagus
Table 1 Baseline characteristics of mitral valve operated patientsaaAF, atrial fibrillation; LA, left atrium; LVEDD, left ventricular end-diastolic.

Table 1 Baseline characteristics of mitral valve operated patientsaaAF, atrial fibrillation; LA, left atrium; LVEDD, left ventricular end-diastolic.
Table 2 Laboratory and echocardiographic values before LVAD implantation in the two groups. From: Reversibility of fixed pulmonary hypertension in left.

Table 2 Laboratory and echocardiographic values before LVAD implantation in the two groups. From: Reversibility of fixed pulmonary hypertension in left.
Table 1 Comparison of perioperative patient characteristics by groups

Table 1 Comparison of perioperative patient characteristics by groups
Fig. 1 Log-rank test comparing survival in patients undergoing surgical repair with those treated with TEVAR. Black line: TEVAR; grey line: surgical repair.

Fig. 1 Log-rank test comparing survival in patients undergoing surgical repair with those treated with TEVAR. Black line: TEVAR; grey line: surgical repair.
Table 1 Hospital mortality

Table 1 Hospital mortality
Fig. 1. Number of patients treated with extracorporeal membrane oxygenation (ECMO) during the period 2001-2011. Graphical representation of ECMO utilization.

Fig. 1. Number of patients treated with extracorporeal membrane oxygenation (ECMO) during the period Graphical representation of ECMO utilization.

Similar presentations

Ads by Google